Skip to main content

Companies implementing Model-Informed Drug Development (MIDD)

Model-informed drug development (MIDD) employs quantitative modeling techniques throughout the drug development lifecycle to support decisions such as dose selection, efficacy justification, trial design, and policy guidance.

List of companies that implement Model-Informed Drug Development (MIDD)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United Kingdom

Pharmaceutical Manufacturing

98k

$35B

Model-Informed Drug Development (MIDD)

United Kingdom

Pharmaceutical Manufacturing

83k

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

39k

$46B

Model-Informed Drug Development (MIDD)

United States

Biotechnology Research

21k

$26B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

43k

Model-Informed Drug Development (MIDD)

United States

Biotechnology Research

9.2k

$10B

Model-Informed Drug Development (MIDD)

Japan

Pharmaceutical Manufacturing

37k

$31B

Model-Informed Drug Development (MIDD)

United States

Pharmaceutical Manufacturing

1.9k

Model-Informed Drug Development (MIDD)

Switzerland

Biotechnology Research

108k

$68B

Model-Informed Drug Development (MIDD)

United States

Biotechnology

17k

$12B

Model-Informed Drug Development (MIDD)

Showing top companies out of 423 that implement Model-Informed Drug Development (MIDD). Get the full list on TheirStack.

Frequently asked questions